FeesSafety
Pluang+

Investigation launched into Integra LifeSciences over alleged securities fraud after revenue misses.

Market News
28 Oct 2026, 00:59 WIB
GlobeNewsWire
View Source
Bearish
Investigation launched into Integra LifeSciences over alleged securities fraud after revenue misses.

Pomerantz LLP is investigating Integra LifeSciences and some of its executives for possible securities fraud following the company's revenue shortfall announcements. Integra cut its 2026 revenue guidance by $30.5 million due to severe flooding at its Cincinnati facility, which disrupted operations and impacted quarterly revenues. The stock price dropped significantly after these disclosures. The investigation aims to determine if the company misled investors about its financial health and operational challenges.

Integra LifeSciences Holding Corporation is under investigation following its revenue guidance cut. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 05:02 WIB: out of 150 priced US health stocks, 90 rose and 60 fell. Notable movers include SYRE at USD 98.88 (+6.43%), MESO at USD 13.18 (+6.38%), and RXRX at USD 4.04 (+6.32%) with a Pluang order activity of 99% Sell / 1% Buy.

More News

Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats

Drone defense market to hit $18.19B by 2030 with 30.6% CAGR amid rising security threats

The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...

Market News
Bullish
1 hour ago
Vallourec to release Q3 2026 results on Nov 20 with CEO and CFO presentation.

Vallourec to release Q3 2026 results on Nov 20 with CEO and CFO presentation.

Vallourec will publish its Q3 2026 financial results on November 20, 2026, at 07:30 AM CET. The company's CEO Philippe Guillemot and CFO Nathalie Delbreuve will present the results via a conference call and webcast at 09:30 AM CET the same day. Inves...

Company Fundamentals
Neutral
4 hours ago
Clearfield schedules Q4 2026 earnings call for Nov 10 to discuss financial results.

Clearfield schedules Q4 2026 earnings call for Nov 10 to discuss financial results.

Clearfield, Inc. announced it will release its fiscal fourth quarter 2026 earnings on November 10, 2026, after market close. The company will hold a conference call at 5:00 p.m. Eastern time to discuss the results with investors. Financial details an...

Company Fundamentals
Neutral
4 hours ago
Law firm probes Enova International over possible securities fraud after bank deal collapse.

Law firm probes Enova International over possible securities fraud after bank deal collapse.

Pomerantz LLP is investigating claims against Enova International and some of its executives for potential securities fraud following Enova's withdrawal of its application to acquire Grasshopper Bancorp, which would have made it a bank holding compan...

Market News
Bearish
4 hours ago
INVO Fertility announces 1-for-4 reverse stock split effective October 30, 2026

INVO Fertility announces 1-for-4 reverse stock split effective October 30, 2026

INVO Fertility, a healthcare company specializing in fertility clinics and technologies, will implement a 1-for-4 reverse stock split effective October 30, 2026. This means every 4 shares will be consolidated into 1 share, reducing the total shares o...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App